Metabolomics in the field of Oncology / Cancer Metabolomics

Metabolomics cancer research is being used to discover diagnostic cancer biomarkers in the clinic and in a research institute, to a better understand its complex heterogeneous nature, to discover pathways which involved in cancer that could be used for new targets and to monitor metabolic biomarkers during therapeutic intervention. These metabolomics approaches may also provide evidence to personalized cancer treatments by providing useful information to the clinician about the cancer patient’s response to medical interventions. The ultimate aims of most metabolomics cancer studies are to discover cancer-specific diagnostic, prognostic or predictive biomarkers for a patient. Untargeted metabolomics is an important and excellent tool for probing cancer-altered biochemical pathways.

 

    Related Conference of Metabolomics in the field of Oncology / Cancer Metabolomics

    March 15-16, 2021

    12th Tissue Repair and Regeneration Congress

    Dubai, UAE
    March 28-29, 2021

    11th Glycobiology World Congress

    Vienna, Austria
    April 19-19, 2021

    2nd International Conference on Nucleic Acids

    London, UK
    June 11-12, 2021

    25th Global Congress on Biotechnology

    Berlin, Germany
    September 13-14, 2021

    17th World Congress on Structural Biology

    Prague, Czech Republic
    September 27-28, 2021

    25th European Biotechnology Congress

    Dublin, Ireland

    Metabolomics in the field of Oncology / Cancer Metabolomics Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in